Physician profile
Luis A Vascello
NPI 1679668065
$16,901.05
in general payments reported to CMS, 2019-2025
22 companies · $2,557 in 2025
The $2,557 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,316 · 2020: $300 · 2021: $252 · 2022: $3,299 · 2023: $3,730 · 2024: $3,447 · 2025: $2,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,909 · Travel and Lodging: $3,978 · Education: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,909.21 |
| Travel and Lodging | $3,977.59 |
| Education | $847.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,112.52 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Medtronic USA, INC. | $3,186.41 | 2019 | |
| Boston Scientific Corporation | $3,106.21 | 2021-2025 | Superion Indirect Decompression System, Clinical Trial Product, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $1,377.60 | 2020-2024 | Senza |
| Spinal Simplicity, LLC | $1,320.64 | 2024 | Ha Minuteman G3-R |
| Spinefrontier, INC. | $1,059.34 | 2025 | Facetfuse, Nanofuse, Sijfuse |
| Painteq LLC | $863.71 | 2023-2024 | Painteq |
| Globus Medical, INC. | $740.83 | 2025 | Senza, Vyrsa V1 |
| Abbott Laboratories | $473.07 | 2019-2023 | Eterna, Proclaim |
| Saluda Medical Americas, INC. | $123.81 | 2023-2025 | Evoke, Evoke Scs |
| Spr Therapeutics, INC | $116.58 | 2023-2025 | Sprint Pns System |
| Biotronik Nro, INC. | $103.77 | 2025 | Prospera |
| Vertos Medical, INC. | $95.74 | 2019-2024 | Mild Device Kit |
| Relievant Medsystems, INC. | $56.93 | 2022 | |
| Averitas Pharma INC. | $37.31 | 2023-2024 | Qutenza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $24.00 | 2025 | Trelstar |
| Flowonix Medical Incorporated | $21.18 | 2020 | |
| Tersera Therapeutics LLC | $18.93 | 2023 | Prialt |
| Neuronetics, INC. | $17.49 | 2022 | |
| Avanos Medical | $16.40 | 2024 | Generator |
| Mml US, INC. | $14.58 | 2025 | Reactiv8 |
| Curonix LLC | $14.00 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Vascello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.